Insight Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,733
Closed -$203K 293
2023
Q1
$203K Sell
2,733
-3,318
-55% -$278K 0.05% 283
2022
Q4
$563K Sell
6,051
-44
-0.7% -$4.25K 0.2% 136
2022
Q3
$581K Buy
6,095
+243
+4% +$24.1K 0.23% 115
2022
Q2
$576K Buy
5,852
+361
+7% +$35.2K 0.2% 130
2022
Q1
$555K Buy
5,491
+2,144
+64% +$225K 0.17% 158
2021
Q4
$345K Buy
+3,347
New +$309K 0.1% 227
2021
Q3
Sell
-5,064
Closed -$417K 316
2021
Q2
$417K Sell
5,064
-3,745
-43% -$307K 0.13% 199
2021
Q1
$677K Buy
8,809
+2,619
+42% +$191K 0.21% 125
2020
Q4
$423K Buy
+6,190
New +$403K 0.16% 167

Other funds holding CVS

Insight Advisors's CVS Position: Q2 2023 in Review

Insight Advisors sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,733 shares — an estimated $203K sold.

Insight Advisors first reported a position in CVS in Q4 2020 and held it in 9 quarters. The position peaked at $677K in Q1 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Insight Advisors reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Insight Advisors sold 2,733 CVS Health shares in Q2 2023, an estimated $203K.
  • Insight Advisors first reported a position in CVS Health in Q4 2020 and held it in 9 quarters.
  • Insight Advisors's CVS Health position peaked at $677K in Q1 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Insight Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.